Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VALEANT PHARMACEUTICALS INTL INC T.VRX

"Valeant Pharmaceuticals is a global specialty pharmaceutical firm with a focus on branded products for the dermatology, gastrointestinal, and ophthalmology markets. The firm also has a branded generics business that operates primarily in Latin America, Eastern Europe, and Asia."


TSX:VRX - Post by User

Post by Carlos66on Aug 10, 2016 2:31pm
128 Views
Post# 25127403

asset sales

asset sales---since they paid way more for their acquisitions than they are worth today how do you get out of debt. Debt outweighs assets. You can't get away from that fact.
---the assets are not going to gain in value more than their debt before the debt comes due.
---it doesn't matter how much they get for a particular asset it is not going to be worth more than what they paid for it & they can't raise prices to compensate for the difference.
---as has been said if they can't sell what they bought years ago for twice their original value VRX will go to ZERO.

carlos
<< Previous
Bullboard Posts
Next >>